Florida Pays $82 Million for Empty Drug Import Plan
The state has not imported any prescription drugs from Canada despite paying millions to a logistics contractor.
Updated on Oct. 28, 2026 in Healthcare

Live Poll
Should states pursue government-run programs to import prescription drugs to lower costs for the public?
Florida has paid LifeScience Logistics over $81.9 million for a state prescription drug import program that has yet to bring a single shipment into the country. The initiative, intended to source cheaper medication from Canada, has been ongoing since 2020.
Why it matters
The program was designed to lower costs for state-run healthcare services by importing medications from Canada. State officials attribute the lack of progress to resistance from pharmaceutical manufacturers.
The state has paid LifeScience Logistics $81,946,746.74 since 2020 to manage a Lakeland warehouse facility. This includes an initial contract of $38.8 million and an additional $43.5 million added during a 2022 renewal.
The players
LifeScience Logistics
This Dallas-based company was hired to manage the warehouse facility required for Florida's pharmaceutical import initiative.
Florida Agency for Health Care Administration
This state department is responsible for managing Florida's healthcare programs and oversaw the contract negotiations for the drug import project.
Ron DeSantis
As the Governor of Florida, he has been a prominent advocate for the state policy to import prescription drugs from Canada.
The details
The Agency for Health Care Administration secured the contract after no other companies bid on the program, which requires a specialized warehouse in Lakeland. Although the FDA approved the program in 2024 and extended it in May 2026, the state has halted payments to the contractor as of July 2026.
Timeline
Florida Gov. DeSantis championed the import plan in 2019.
The contract with LifeScience Logistics was signed on Dec. 30, 2020.
Florida renewed the logistics contract for three years in Dec. 2022.
The FDA approved the state drug import program in 2024.
Reports confirmed zero drugs were imported between April and June 2026.
Market Landscape
Florida's initiative operates within the regulatory framework established by the FDA's 2020 final rule on the importation of prescription drugs. This program reflects a broader state-level push to bypass traditional pharmaceutical distribution channels in an attempt to lower costs.
The state's failure to import drugs means that residents have not yet seen any change in prescription prices resulting from this specific initiative. Taxpayers continue to fund the maintenance of a Lakeland warehouse facility that is currently not fulfilling its intended purpose.
The takeaway
Large-scale government import programs face significant logistical and industry-level hurdles that can delay implementation for years. Residents should monitor future state reporting to see if the program ever achieves its goal of reducing costs for state-run medical services.
Further reading
For more on state healthcare policy, visit the Florida Healthcare section.
Source note: This article includes information reported by WKMG.
Live Poll
Should states pursue government-run programs to import prescription drugs to lower costs for the public?









